Most Recent Articles by Nicole Blazek
Risk stratification, drug screening, and pharmacogenetic testing should guide prescribing habits.
As government regulation increases to control opioid abuse, legitimate pain management practitioners are at risk for being unfairly stigmatized.
Encouraging initial findings support developing specialized clinics to manage complicated and high-risk patients on opioid therapy.
From unethical providers to doctor-shopping patients and internet pharmacies, determined individuals can obtain controlled substances in many ways.
The pros and cons of intranasal, intramuscular, and autoinjector routes of administration.
More Articles by Nicole Blazek
Clinical Pain Advisor Articles
- Virtual Reality for Pain Relief: Understanding the Underlying Mechanisms
- Vibrating Gloves Significantly Reduce Osteoarthritis-Related Hand Pain
- Neuroinflammation in Neuropathic Pain Indicated by Elevated Levels of Proinflammatory Chemokines in CSF
- Neuroimaging for Chronic Pain: IASP Consensus Statement
- Hypertension in Chronic Pain: Risk Factors
- Liposomal Bupivacaine Effective for Shoulder Arthroplasty-Related Pain
- Reducing the P-Value for Statistical Significance to Improve the Quality of Research?
- FDA's Strategies for Managing Patients Taking CNS Depressants and Opioids
- Electrotherapy, Acupuncture May Decrease Pain Following Total Knee Arthroplasty
- Low-Dose Oromucosal Ibuprofen Effective for Relieving Sore Throat
- Survey Finds Teens Divided on Beliefs and Attitudes of Prescription Drug Abuse
- HIV-Positive Patients Experience Frequent Headaches
- Low-Dose Perineural Dexamethasone Prolongs Effects of Brachial Plexus Nerve Block
- Business Savvy Tips for Buying a Practice
- Diphenhydramine Decreases Pain During Colonoscopy for Chronic Opioid Users